• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Veritas Signs MOU with Puerto Rican Chamber of Commerce and More

August 13, 2018


VANCOUVER, British Columbia, Aug. 13, 2018 — /D.M.O. Newswire/ —  Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) and (Frankfurt: 2VP) (“Veritas” or the “Company) is pleased to announce that it has entered into a Memorandum of Understanding (“MOU”) with the Chamber of Commerce, Industry, Services and Tourism Brazil & Puerto Rico (“C2BPR”) with the aim of helping to commence, maintain, and expand businesses in the medical cannabis sector for the Brazil and Puerto Rico markets.


Under the terms of the MOU, both parties will advise each other of events that may impact its mission; suggest speakers to participate in workshops, conferences, seminars and other related events. Both parties will also discuss bilateral trade between Veritas & C2BPR and other commercial topics; provide each other with information on business opportunities that may become available to Veritas about the Brazilian & Puerto Rican markets; and lastly support each other, as long as possible, in coordinating and promoting related seminars and conferences. 


For more information about C2BPR, please visit their website at: www.c2bpr.com


Veritas Pharma’s CEO, Dr. Lui Franciosi, stated, “We are delighted to work with C2BPR on addressing business communities in Brazil and Puerto Rico where the focus is opening up markets for scientifically-based medical cannabis products.”  By sharing its knowledge and experience of medical cannabis from its bases in Puerto Rico and Canada, Veritas Pharma aims to educate all stakeholders, particularly, in Brazil about the pharmacological evaluation and the therapeutic value of cannabis products such as the Company’s Cannevert brand.


The Company also announces the issuance of 500,000 stock options at $0.22 to a consultant of the Company for a term of twelve (12) months.


About Veritas Pharma Inc. 

Veritas Pharma Inc. is an emerging pharmaceutical and IP development company, who, through its 100% owned subsidiary Cannevert Therapeutics Ltd. (“CTL“), is advancing the science behind medical cannabis. It is the Company’s aim, through its investment in CTL, to develop the most effective cannabis strains (cultivars) specific to pain, nausea, epilepsy and PTSD, solving the critical need for clinical data to support medical marijuana claims. CTL’s unique value proposition uses a low-cost research and development model to help drive shareholder value, and speed-to-market. Veritas’ investment in CTL is led by a strong management team, bringing together veteran academic pharmacologists, anesthetists & chemists. The company’s commercial mission is to patent protect IP (cultivars & strains) and sell or license to cancer clinics, insurance industry and pharma, targeting multi-billion-dollar markets according to Deloitte’s Insights and Opportunities.


Veritas Pharma Inc. is a publicly traded company in Canada, on the Canadian Stock Exchange under the ticker VRT; in the United States, on the OTC under the ticker VRTHF; and in Germany, on the Frankfurt exchange under the ticker 2VP.


For more information, please visit our website: veritaspharmainc.com


On behalf of the Board of Directors

"Dr. Lui Franciosi"
Dr. Lui Franciosi
President and Chief Executive Officer


Further information about the Company is available on our website at www.veritaspharmainc.com or under our profile on SEDAR at www.sedar.com and on the CSE website at www.thecse.com.


Investor and Public Relations Contact
Veritas Pharma Inc.
Sam Eskandari
Telephone: +1.416.918.6785 
Email: ir@veritaspharmainc.com
Website: www.veritaspharmainc.com 


The CSE has not reviewed, nor approved or disapproved the content of this press release.

Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.